Consider this arc: peptides were around in niche communities, GLPs from Pharma then exploded, people realized they could take less or source them elsewhere, regulation enters & now gray & black market are going bye-bye & companies like HIMs & clean compounders are set to soar.

The same general arc occurred for T, vasodilators, and stimulants “for ADHD”. Can’t keep a good thing down? Or USA loves their pills & potions and won’t stop finding new ways to find, sell and take em?

This drives certain MD’s absolutely bonkers. Because they lost the steering wheel. Well trained MDs embracing peptides from different sources (pharma and compounding) are going to be a mainstay. This is a different category than we are typically familiar with. They’re not influencers, they’re not standard docs, but they’re board certified MDs working in concert with different corners of the Rx market than is typical.

PS: GLPs obviously the big ones but they’ve pulled BPC and others into their wake and that’s why you’re unlikely to see heavy regulation provided things are coming from compounding pharmacies… also the FDA just loosened the belt. (Inverse pun intended).